173 countries have drug-resistance plans, WHO survey finds


In countries’ self-assessments, 22% said their plans had both necessary funding and full implementation, while 36% reported a national reference laboratory equipped to test selected bacteria and fungi.
A World Health Organization (WHO) survey found that 173 countries had developed plans to address antimicrobial resistance, up from 79 in 2017. The findings, released on 16 November 2026, are based on countries’ assessments of their own actions.
Among participating countries, 22% reported both the necessary funding and full implementation of their plans. Only 36% reported a national reference laboratory equipped to test the selected bacteria and fungi.
Antimicrobial resistance occurs when medicines lose effectiveness against bacteria and other microbes. Common infections then become harder to treat, and procedures such as surgery, childbirth and cancer care become riskier.
The annual self-assessment was completed by 183 countries, representing 94% of WHO member states. It tracks what countries say they are doing, rather than measuring how common resistant infections are. The survey began in 2016, was developed by the Quadripartite organizations FAO, UNEP, WHO and WOAH, and also helps monitor commitments under the 2024 UN General Assembly political declaration on antimicrobial resistance.
Countries also reported gaps in guidance and monitoring: 63% said they had guidelines on appropriate antimicrobial use, while just over half said they had systems to monitor national antibiotic use and resistance levels.
WHO says inadequate testing raises the risk that patients will receive ineffective or unnecessary antibiotics and that resistant infections and outbreaks will go undetected.
WHO Director-General called on countries to invest in infection prevention, monitoring, equitable access to essential antimicrobials and quality diagnostics. He said:

Every infection prevented means fewer antimicrobials are needed, and testing ensures that patients receive the right treatment only when necessary.
WHO released two tools to help clinical laboratories diagnose bacterial and fungal infections: a prioritized catalog of tests and step-by-step methods. The global target is for 80% of countries to have comprehensive bacterial and fungal resistance testing capacity by 2030.
Researchers used an insulated chamber to transmit information without an actively generated radio signal. They plan to test the system in noisier settings and with multiple transmitters.
3 min

Anutin Charnvirakul ordered alternative supplies and close monitoring after water was suspended to 14 villages where arsenic at the local waterworks reached 30 times the safe limit.
3 min

Lawmakers voted 53 in favor, with none against and 29 abstentions. The bill would extend coverage to around 350,000 lower-paid employees, but it still needs a second reading and full approval to become law.
2 min